Fibroblast stimulation in schistosomiasis. I. Stimulation in vitro of fibroblasts by soluble products of egg granulomas.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 6268716)

Published in J Infect Dis on September 01, 1981

Authors

D J Wyler, S M Wahl, A W Cheever, L M Wahl

Articles citing this

Granulomatous inflammation--a review. J Clin Pathol (1983) 2.15

Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev (1989) 1.79

Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect Immun (2003) 1.35

Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts. Am J Pathol (1994) 1.16

Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection. Infect Immun (1996) 1.12

Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis. J Exp Med (1986) 1.02

Regulation of granulomatous inflammation in experimental models of schistosomiasis. Infect Immun (2004) 0.92

Direct and indirect effects of soluble extracts of Schistosoma mansoni eggs on fibroblast proliferation in vitro. Infect Immun (1982) 0.87

Activation of jird (Meriones unguiculatus) macrophages by the filarial parasite Brugia pahangi. Infect Immun (1984) 0.84

Eosinophil chemotactic lymphokine produced by egg-associated granulomas in murine schistosomiasis japonicum. Infect Immun (1986) 0.83

Isolated hepatic granulomas from mice infected with Schistosoma mansoni contain nerve growth factor. Infect Immun (1991) 0.80

Cloning and analysis of murine cDNA that encodes a fibrogenic lymphokine, fibrosin. Proc Natl Acad Sci U S A (1995) 0.77

Schistosomal egg granuloma-derived fibroblast-stimulating factor is apparently distinct from interleukin-1. Infect Immun (1989) 0.75

Fibroblast-stimulating factor 1, a novel lymphokine produced in schistosomal egg granulomas, stimulates liver fat-storing cells in vitro. Infect Immun (1993) 0.75

Articles by these authors

N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A (1975) 9.24

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol (1999) 5.58

Perspectives on the basic reproductive ratio. J R Soc Interface (2005) 5.34

Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol (2001) 4.59

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest (1999) 4.22

Macrophages as a source of HIV during opportunistic infections. Science (1997) 3.92

Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol (1997) 3.79

Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J Exp Med (1998) 3.56

Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55

Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55

Mutual information without the influence of phylogeny or entropy dramatically improves residue contact prediction. Bioinformatics (2007) 3.42

Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol (1984) 3.36

Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol (1993) 3.34

Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev (1989) 3.21

TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity (2001) 3.20

Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol (1978) 3.16

Collagenase production by endotoxin-activated macrophages. Proc Natl Acad Sci U S A (1974) 3.05

IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol (2000) 3.03

Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03

Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00

Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med (1994) 2.99

Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med (1993) 2.98

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest (1995) 2.95

Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol (1988) 2.70

Collagenase production by lymphokine-activated macrophages. Science (1975) 2.64

Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ (1968) 2.58

Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today (1989) 2.56

Using information theory to search for co-evolving residues in proteins. Bioinformatics (2005) 2.53

An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature (1995) 2.52

Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med (2000) 2.48

Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood (1997) 2.41

Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39

Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages. J Immunol (1981) 2.39

Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol (1991) 2.39

Role of a peptidase in phagocyte chemotaxis. Proc Natl Acad Sci U S A (1976) 2.38

Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci U S A (1990) 2.37

Multiplication of Leishmania in human macrophages in vitro. Infect Immun (1979) 2.30

Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol (1991) 2.23

Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med (1994) 2.22

A quantitative post-mortem study of Schistosomiasis mansoni in man. Am J Trop Med Hyg (1968) 2.22

Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med (1990) 2.19

Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest (1991) 2.18

Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest (1991) 2.11

Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest (1984) 2.10

IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J Immunol (1997) 2.09

Peripheral lymphocyte subpopulations in human falciparum malaria. Clin Exp Immunol (1976) 2.03

Tumor-associated macrophages as targets for cancer therapy. J Natl Cancer Inst (1998) 2.01

Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect Immun (2001) 1.99

Transforming growth factor beta: a matter of life and death. J Leukoc Biol (1994) 1.97

Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci U S A (1977) 1.96

Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J Biol Chem (1993) 1.95

IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol (1999) 1.91

Lymphocyte transformation in human Plasmodium falciparum malaria. J Immunol (1974) 1.91

Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology (2001) 1.90

Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol (1990) 1.88

The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Comparative studies in arthritis resistant and susceptible inbred rat strains. Arthritis Rheum (1983) 1.83

Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med (2001) 1.82

Malaria--resurgence, resistance, and research. (First of two parts). N Engl J Med (1983) 1.82

Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol (1998) 1.79

Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol (1999) 1.78

Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. J Infect Dis (1990) 1.77

Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2010) 1.76

Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats. J Clin Invest (1985) 1.73

Improving estimates of the basic reproductive ratio: using both the mean and the dispersal of transition times. Theor Popul Biol (2006) 1.71

Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol (1999) 1.70

An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J Infect Dis (1980) 1.70

Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J Exp Med (1996) 1.68

Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci U S A (1996) 1.68

Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest (1997) 1.67

NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am J Pathol (2000) 1.67

Mutation of Tec family kinases alters T helper cell differentiation. Nat Immunol (2001) 1.63

Pathological lesions associated with Schistosoma mansoni infection in man. Trans R Soc Trop Med Hyg (1967) 1.61

NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. Ann Intern Med (1984) 1.61

Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells. J Immunol (1996) 1.60

Macrophage production of fibronectin, a chemoattractant for fibroblasts. J Immunol (1981) 1.58

CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med (1998) 1.56

Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol (2001) 1.55

Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells. J Immunol (1995) 1.55

IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol (1998) 1.54

Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol (1999) 1.53

Spleen-derived mononuclear cell chemotactic factor in malaria infections: a possible mechanism for splenic macrophage accumulation. J Immunol (1977) 1.53

Induction of guinea pig B-cell lymphokine synthesis by mitogenic and nonmitogenic signals to Fc, Ig, and C3 receptors. J Exp Med (1974) 1.53

The fixation probability of beneficial mutations. J R Soc Interface (2008) 1.52

Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol (1996) 1.51

Malaria antigen-specific T-cell responsiveness during infection with Plasmodium falciparum. Clin Exp Immunol (1977) 1.50

Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med (1999) 1.49

Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem (1992) 1.46

In vitro studies of a chemotactic lymphokine in the guinea pig. Int Arch Allergy Appl Immunol (1974) 1.46

Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic. J Immunol (1984) 1.45

Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood (1990) 1.42